Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6246328 | Transplantation Proceedings | 2014 | 7 Pages |
Abstract
Systemic injection of MSC did not improve recipient survival. In vivo imaging showed MSCs trapped in the lung that later became undetectable. Ex vivo injection of MSCs did show a benefit without adverse effects. At Day 14 after RTx, 75% of the rats in the AT-MSC-injected group (MSC[+]) had survived, whereas 50% of the rats in the AT-MSC-non-injected group (MSC[â]) had died. Renal function in the MSC(+) group was improved compared with that in the MSC(â) group at Day 4. LacZ staining revealed AT-MSCs attached to the renal tubules at 24 hours after RTx that later became undetectable. Histopathologic examination showed little difference in fibrosis between the groups at Day 14. No teratomas or other abnormalities were seen at 3 months.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
S. Iwai, I. Sakonju, S. Okano, T. Teratani, N. Kasahara, S. Yokote, T. Yokoo, E. Kobayash,